Cancer program annual report 2010 - Evangelical Community Hospital

More documents

Recommendations

Info

cancer liaison report The year 2010 has been marked by many accomplishments for the Cancer Committee at Evangelical Community Hospital. For the first time on a consistent basis, Continuing Medical Education (CME) credits are available for physician participants and Continuing Education Units are available for all other participants in cancer conferences (Tumor Board). 2 “Many thanks are due to Cynthia Miller, CTR, for her diligence in collecting the Tumor Registry data and in readying us for the upcoming CoC accreditation survey.” John F. Turner, MD, FACS We are seeing increased primary care participation in cancer conferences and continue to work towards even greater participation. Care for our patients has been positively impacted by the involvement of their primary care providers in these conferences. Currently, all cases presented at the weekly breast Virtual Tumor Board and the majority of cases presented at the monthly General Tumor Board are presented prospectively (during the active decision-making process, prior to definitive therapy). We once again had a very successful Mammathon, making more than 4,000 calls and speaking with more than 1,600 women. Close to 900 committed to have their mammogram and 164 scheduled their mammogram that day for a positive outcome of 53 percent. We served more than 100 women at the annual Women’s Health Screening event. As our tumor registry continues to grow, we are receiving valuable data, which influence the organization and procedures of our cancer programs and are utilized in analyzing the quality of cancer care. Gary Ayers, DO, and the director of the Gastrointestinal Malignancy Clinic, will be discussing the registry’s colon cancer statistics elsewhere in this report. Below are the data from the registry entered into the American College of Surgeons Commission on Cancer (CoC) CP3R quality measures for breast cancer study: 1. Radiation therapy is administered within one year (365 days) of diagnosis for women under age 70 receiving breast-conserving surgery for breast cancer. • 100 percent compliance 2. Combination chemotherapy is considered or administered within four months (120 days) of diagnosis for women under age 70 with American Joint Committee on Cancer (AJCC) T1CN0M0, or Stage II or III hormone receptor negative breast cancer. • 100 percent compliance 3. Tamoxifen or third-generation aromatase inhibitor is considered or administered within one year (365 days) of diagnosis for women with AJCC T1CN0M0, or Stage II or III hormone receptor positive breast cancer. • 27/28 patients met this criterion (96 percent) • One patient had hormonal treatment delay due to complications during chemotherapy treatment Additionally, the surgeons at the Thyra M. Humphreys Center for Breast Health participated in the Mastery of Breast Surgery quality measure database, and our results compared quite favorably with breast surgeons across the nation in relation to three quality measures. Sincerely, John F. Turner John F. Turner, MD, FACS Cancer Liaison Physician, Breast Surgeon Evangelical Community Hospital
Cancer conferences Cancer conferences, also known as tumor boards, are essential forums to provide multidisciplinary consultative services for patients, and offer education to physicians and healthcare providers. Cancer conferences are a requirement for an accredited program by the CoC. The number of cases presented each year is based on a percentage of annual analytic cases added to the cancer registry database. The CoC requires that at least 10 percent of the annual analytic cases be presented, and 75 percent of the cases discussed need to be presented prospectively with appropriate stage documented for the five major sites seen at our facility. Nationally recognized treatment guidelines such as those outlined by the National Comprehensive Cancer Center Network need to be considered when discussing treatment options. In 2010, there were 11 multidisciplinary cancer conferences held at Evangelical. Primary sites presented were colorectal, lung, prostate, small bowel, lymphoma, thyroid, endometrial, pancreas, bladder, testis, thymus, salivary gland and esophagus. A site-specific conference is held every Tuesday that includes all breast cases. Diagnosis and treatment recommendations are discussed. Primary care physician participation is encouraged for all cancer conferences and was a clinical goal the Cancer Committee achieved in 2010. David Hicks, MD, from the University of Rochester, presented Her2-positive Breast Cancer/Diagnostic Tools and Challenges to the Medical Staff in March. This educational activity was in addition to the multidisciplinary cancer conference; CME credits were provided to the attendees. In April, the Cancer Committee offered educational sessions to the Medical Staff and allied health professionals on AJCC staging for breast, colon, lung and thyroid cancer. Beginning in March 2010, Evangelical partnered with Geisinger Medical Center, and CME credits were granted to Tumor Board/cancer conference attendees. In 2010, there were 11 multidisciplinary cancer conferences held at Evangelical. 3
Page 1 and 2: EVANGELICAL COMMUNITY HOSPITAL CANC
Page 3: A LETTER FROM THE CHAIR Dear Friend
Page 7 and 8: Prevention & Early Detection Progra
Page 9 and 10: lewisburg cancer care, radiation on
Page 11 and 12: Primary Site Tabulation for 2009 Ca
Page 13 and 14: Number of Patients 10 8 6 4 2 0 Fig
Page 15 and 16: eing said, mitigating circumstances

Cancer program annual report 2010 - Evangelical Community Hospital

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?